Are you a professional? Activate your profile

Are you already registered? Access Forgot your password?

Financial advisors
Calculation tools
- Calculates the risk and return of a securities portfolio
- Calculate your supplementary pension
News from the UK Stock Exchange

Funds / ETFs / Stock Ranking
Learn about finance
- Financial glossary
- Learning to invest
  The most important concepts of finance
Study Office
- Asset allocation
- Finance app ranking
About us

Aurora Cannabis Inc. - news published 136 - readings 3.099

BACK

Aurora Cannabis Inc.

Aurora Cannabis Announces Breakthrough Discovery of Powdery Mildew Resistant Cultivars (Form 6-K)

Aurora Cannabis Announces Breakthrough Discovery of Powdery Mildew Resistant Cultivars NASDAQ | TSX: ACB Groundbreaking research at Aurora Coast, Aurora's world-class research and development facility, sets new standard in cannabis science EDMONTON, AB, March 20, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis comp ...

20.03.2025

Aurora Cannabis Inc.

Breaking Down Barriers: Aurora Cannabis Eases Patient Access to High Quality Medical Cannabis Products in Australia (Form 6-K)

Breaking Down Barriers: Aurora Cannabis Eases Patient Access to High Quality Medical Cannabis Products in Australia NASDAQ | TSX: ACB Largest Global Medical Cannabis Company Operating in Nationally Regulated Markets, Aurora Removes Concession Card Requirements to Access IndiMed Products in Australia EDMONTON, AB, Feb. 14, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company&qu ...

18.02.2025

Aurora Cannabis Inc.

Appointment of Agent (Form F-X)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-X APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING A. Name of issuer or person filing ("Filer"): Aurora Cannabis Inc. B. (1) This is [check one]: ☒ an original filing for the Filer ☐ an amended filing for the Filer (2) Check the following box ...

14.02.2025

Aurora Cannabis Inc.

Voluntary Supplemental Material by Foreign Issuer (Form SUPPL)

Table of Contents Filed pursuant to General Instruction II.L of Form F-10; File No. 333-284958 PROSPECTUS SUPPLEMENT TO THE SHORT FORM BASE SHELF PROSPECTUS DATED FEBRUARY 14, 2025 New Issue February 14, 2025 AURORA CANNABIS INC. 7,040,875 Common Shares This Prospectus Supplement relates to: (i) up to 7,040,875 common shares (the Warrant Shares ) of Aurora Cannabis Inc. ( ...

14.02.2025

Aurora Cannabis Inc.

Registration Statement by Canadian Issuer (Form F-10)

As filed with the Securities and Exchange Commission on February 14, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form F-10 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AURORA CANNABIS INC. (Exact name of Registrant as specified in its charter) British Columbia, Canada 2833 Not Applicable (State or other ...

14.02.2025

Aurora Cannabis Inc.

Aurora Cannabis Announces Supply Agreement with SNDL (Form 6-K)

Aurora Cannabis Announces Supply Agreement with SNDL NASDAQ | TSX: ACB Agreement Complements Existing Relationship Focused on the Supply of Premium Cannabis EDMONTON, AB, February 6, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) -the Canadian based leading global medical cannabis company, is pleased to announce a str ...

07.02.2025

Aurora Cannabis Inc.

Earnings Call TranscriptPDF (ACB 3Q25 Earnings Call Transcript)

Corrected Transcript 05-Feb-2025 Aurora Cannabis, Inc. (ACB.CA) Q3 2025 Earnings Call Total Pages: 15 1-877-FACTSET www.callstreet.com Copyright © 2001-2025 FactSet CallStreet, LLC Aurora Cannabis, Inc. ( ACB.CA) Corrected Transcript Q3 2025 Earnings Call 05-Feb-2025 CORPORATE PARTICIPANTS Kevin Niland Simona King Director-Strategic Finance & Investor Relations, Aurora Ca ...

06.02.2025

Aurora Cannabis Inc.

Management Discussion & AnalysisPDF (MDA 202421 Q3 2025 FINAL)

AURORA CANNABIS INC. Management's Discussion & Analysis For the three and nine months ended December 31, 2024 and 2023 (in Canadian Dollars) Management's Discussion & Analysis Table of Contents Business Overview 3 Condensed Statement of Comprehensive Income (Loss) 5 Key Quarterly Financial Results 6 Key Developments During and Subsequent to Three Months Ended December ...

05.02.2025

Aurora Cannabis Inc.

Financial StatementsPDF (FS 202421 Q3 2025 FINAL)

AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three and nine months ended December 31, 2024 and 2023 (in Canadian Dollars) Table of Contents Condensed Consolidated Interim Statements of Financial Position 3 Condensed Consolidated Interim Statements of Income (Loss) and Comprehensive Income (Loss) 4 Condensed Consolidated Interim S ...

05.02.2025

Aurora Cannabis Inc.

Aurora Cannabis Announces Fiscal 2025 Third Quarter Results (Form 6-K)

Aurora Cannabis Announces Fiscal 2025 Third Quarter Results NASDAQ | TSX: ACB Reports Total Net Revenue 1 of $88.2 Million, up 37% YoY, Including Record Net Revenue 1 of $68.1 Million in Global Medical Cannabis, up 51% YoY Generates Record Net Income of $31.2 Million, up 282% YoY, and Record Adjusted EBITDA 1 of $23.1 Million, up 316% YoY Achieves Target of Positive Free Cash ...

05.02.2025

Aurora Cannabis Inc.

Condensed Consolidated Interim Financial Statements (Form 6-K)

Condensed Consolidated Interim Financial Statements (Unaudited) For the three and nine months ended December 31, 2024 and 2023 (in Canadian Dollars) Table of Contents Condensed Consolidated Interim Statements of Financial Position 3 Condensed Consolidated Interim Statements of Income (Loss) and Comprehensive Income (Loss) 4 Condensed Consolidated Interim Statements of Changes ...

05.02.2025

Aurora Cannabis Inc.

Aurora Cannabis to Host Third Quarter 2025 Investor Conference Call (Form 6-K)

Aurora Cannabis to Host Third Quarter 2025 Investor Conference Call NASDAQ | TSX: ACB EDMONTON, AB, Jan. 22, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter 2 ...

24.01.2025

Aurora Cannabis Inc.

2025 Q2 Financial Statements

AURORA CANNABIS INC. Condensed Consolidated Interim Financial Statements (Unaudited) For the three and six months ended September 30, 2024 and 2023 (in Canadian Dollars) Table of Contents Condensed Consolidated Interim Statements of Financial Position 3 Condensed Consolidated Interim Statements of Loss and Comprehensive Loss .................................................... ...

06.11.2024

Aurora Cannabis Inc.

2025 Q2 Management Discussion & Analysis

AURORA CANNABIS INC. Management's Discussion & Analysis For the three and six months ended September 30, 2024 and 2023 (in Canadian Dollars) Management's Discussion & Analysis Table of Contents Business Overview 3 Condensed Statement of Comprehensive Loss 5 Key Quarterly Financial Results 6 Key Developments During and Subsequent to Three Months Ended September 30, 2024 ...

06.11.2024

Aurora Cannabis Inc.

Aurora IR presentation FY25 Q2 Final

I NV ES TOR P RE S E NT A TI O N FY25 Q2 November 2024 Disclaimer CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information contained in this presentation constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this presentation that are not statements of historical fact may be deemed to be forward-looking s ...

06.11.2024

Aurora Cannabis Inc. - news published 136 - readings 3.099

Aurora Cannabis Inc.

Aurora Cannabis Announces Breakthrough Discovery of Powdery Mildew Resistant Cultivars (Form 6-K)

Aurora Cannabis Inc.

Breaking Down Barriers: Aurora Cannabis Eases Patient Access to High Quality Medical Cannabis Products in Australia (Form 6-K)

Aurora Cannabis Inc.

Appointment of Agent (Form F-X)

Aurora Cannabis Inc.

Voluntary Supplemental Material by Foreign Issuer (Form SUPPL)

Aurora Cannabis Inc.

Registration Statement by Canadian Issuer (Form F-10)

Aurora Cannabis Inc.

Aurora Cannabis Announces Supply Agreement with SNDL (Form 6-K)

Aurora Cannabis Inc.

Earnings Call TranscriptPDF (ACB 3Q25 Earnings Call Transcript)

Aurora Cannabis Inc.

Management Discussion & AnalysisPDF (MDA 202421 Q3 2025 FINAL)

Aurora Cannabis Inc.

Financial StatementsPDF (FS 202421 Q3 2025 FINAL)

Aurora Cannabis Inc.

Aurora Cannabis Announces Fiscal 2025 Third Quarter Results (Form 6-K)

Aurora Cannabis Inc.

Condensed Consolidated Interim Financial Statements (Form 6-K)

Aurora Cannabis Inc.

Aurora Cannabis to Host Third Quarter 2025 Investor Conference Call (Form 6-K)

Aurora Cannabis Inc.

2025 Q2 Financial Statements

Aurora Cannabis Inc.

2025 Q2 Management Discussion & Analysis

Aurora Cannabis Inc.

Aurora IR presentation FY25 Q2 Final

You have reached the maximum number of requests. You can no longer send.

Become Member

€2,99per month

Become Member

€2,99per month

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

Become
Member